VRAYLAR Now Reimbursed by the Province of Quebec for Schizophrenia
Winnipeg, Manitoba--(Newsfile Corp. - May 1, 2023) - VRAYLAR (cariprazine) for the treatment of Schizophrenia in adults has received exception medication status on the list of medications in the province of Quebec. This decision will make the drug more accessible, significantly improving the lives of individuals and families affected by Schizophrenia in Quebec."VRAYLAR (cariprazine) can be life-changing for adults living with Schizophrenia because it's the first drug of its kind made...
2023-05-01 9:00 AM EDT
Schizophrenia Society of Canada Launches Cannabis and Mental Health, an Online Suite of Digital Resources
Toronto, Ontario--(Newsfile Corp. - March 22, 2022) - The Schizophrenia Society of Canada is pleased to announce the launch of Cannabis and Mental Health, a comprehensive online suite of digital resources exploring a range of issues surrounding the mental health impacts of cannabis, at the individual, community and societal level. This platform includes a free 90 minute course for youth, and created by youth, as well as a mentor guide with activities for educators, peer support workers,...
2022-03-22 10:35 AM EDT
société canadienne de la schizophrénie lance le cannabis et la santé mentale
Toronto, Ontario--(Newsfile Corp. - 22 mars 2022) - Aujourd'hui, la Société Canadienne de la Schizophrénie est heureuse d'annoncer le lancement de Cannabis et Santé mentale. Cannabis et Santé mentale est un ensemble complet de ressources en ligne qui explore un éventail de questions relatives aux effets du cannabis sur la santé mentale, au niveau individuel, communautaire et sociétal. Cette plateforme comprend un cours gratuit de 90 minutes destiné aux jeunes et créé par des jeunes, ainsi...
2022-03-22 10:35 AM EDT